News
-
-
-
-
PRESS RELEASE
EQS-Adhoc: BayWa AG: Impairment tests lead to extraordinary depreciation of € 222.2 million (impairment tests in accordance with IAS 36)
BayWa AG reports non-cash impairment losses of €222.2 million in Half-Year Financial Statements 2024 due to impairment tests. BayWa r.e. AG is the most affected subsidiary -
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: BayWa AG: Preliminary business figures for the first half of 2024, suspension of forecast and postponement of the publication of half-year figures
BayWa AG releases preliminary business figures for H1 2024, suspends 2024 forecast, and postpones publication of half-year results. Group revenues €10.7B, EBITDA €149.5M